ArticleEuroasian journal of hepato-gastroenterology
Characteristics and Prognostic Factors of Hepatitis B Virus-associated Hepatocellular Carcinoma in Patients with and without Cirrhosis.
Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims and background: This study aimed to evaluate and compare the factors affecting survival in patients with and without cirrhosis who developed hepatocellular carcinoma (HCC) on the background of hepatitis B virus (HBV). Materials and methods: In our retrospective, single-center study, the data of 114 patients who were admitted to our center between January 2012 and January 2021 and who met the inclusion criteria were collected. Factors affecting survival were identified by log-rank and Cox regression analysis. Data of patients with and without cirrhosis were compared. Results: Patients with and without cirrhosis were compared; 64 (56.1%) patients had cirrhosis and it was associated with reduced survival (17 vs 34 months, Conclusion: Prolonged survival was observed with increased BMI levels in patients with non-cirrhotic HCC, even though BMI levels did not differ in both groups ( Clinical significance: Our findings suggest that metabolic factors such as BMI and hypertension may influence the clinical course of HBV-related HCC, especially in non-cirrhotic patients. Recognizing these factors could help identify patients at risk and guide tailored management strategies. How to cite this article: Tekin İE, Simsek C, Balaban HY,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.